Product List
Metformin HCI
PRODUCT LIST
View and download in pdf document (Ver. 7.0_Feb. 2021)
ACTIVE PHARMACEUTICAL INGREDIENTS LIST
INN |
CAS Nº |
MOLECULE / FORMULA |
THERAPEUTIC CATEGORY |
|---|---|---|---|
Atovaquone |
95233-18-4 |
Antimalarial |
|
Atracurium Besylate |
64228-81-5 |
NMBA |
|
Atropine Base |
51-55-8 |
Anticholinergic |
|
Atropine Sulfate |
55-48-1 |
Anticholinergic |
|
Benazepril Hydrochloride |
86541-74-4 |
ACE Inhibitor |
|
Bortezomib |
179324-69-7 |
Antineoplastic |
|
Captopril |
62571-86-2 |
|
ACE Inhibitor |
Chlorambucil |
305-03-3 |
|
Antineoplastic |
Cisatracurium Besylate |
96946-42-8 |
|
NMBA |
Decitabine |
2353-33-5 |
Antineoplastic |
|
Delapril HCl |
83435-67-0 |
|
Antihypertensive / ACE Inhibitor |
Desloratadine |
100643-71-8 |
Antihistaminic |
|
Deutetrabenazine |
1392826-25-3 |
VMAT2 inhibitor |
|
Enalapril Maleate |
76095-16-4 |
ACE Inhibitor |
|
Enalaprilat |
76420-72-9 |
ACE Inhibitor |
|
Enzalutamide |
915087-33-1 |
Antiandrogen |
|
Everolimus |
159351-69-6 |
Antineoplastic |
|
Fosaprepitant Dimeglumine |
265121-04-8 |
Antiemetic |
|
Gefitinib |
184475-35-2 |
Antineoplastic |
|
Gemcitabine Hydrochloride |
122111-03-9 |
Antineoplastic |
|
Lisinopril |
83915-83-7 |
ACE Inhibitor |
|
Loratadine |
79794-75-5 |
Antihistaminic |
|
Metformin Hydrochloride |
1115-70-4 |
Type 2 diabetes |
|
Methotrexate |
59-05-2 |
Antineoplastic |
|
Milrinone |
78415-72-2 |
Cardiotonic |
|
Mivacurium Chloride |
106861-44-3 |
NMBA |
|
Moexipril Hydrochloride |
82586-52-5 |
ACE Inhibitor |
|
Palonosetron Hydrochloride |
135729-62-3 |
Antiemetic |
|
Pemetrexed Disodium |
150399-23-8 |
Antineoplastic |
|
Perindopril Arginine |
612548-45-5 |
ACE Inhibitor |
|
Perindopril Erbumine |
107133-36-8 |
ACE Inhibitor |
|
Pirfenidone |
154229-18-2 |
Antifibrotic |
|
Quinapril Hydrochloride |
82586-55-8 |
ACE Inhibitor |
|
Ramipril |
87333-19-5 |
ACE Inhibitor |
|
Relugolix |
737789-87-6 |
Haematological Agent |
|
Rocuronium Bromide |
119302-91-9 |
NMBA |
|
Silodosin |
160970-54-7 |
Urinary Incontinence |
|
Sirolimus |
53123-88-9 |
Immunosuppressant |
|
Solifenacin Succinate |
242478-38-2 |
Urinary Incontinence |
|
Staurosporine |
62996-74-1 |
Antineoplastic |
|
Sugammadex Sodium |
343306-79-6 |
NMB Reversal |
|
Tacrolimus |
109581-93-3 |
Immunosuppressant |
|
Tetrabenazine(Only for non-US territories) |
58-46-8 |
Antihyperkinetic |
|
Tipiracil Hydrochloride |
183204-72-0 |
Antimetabolite |
|
Trandolapril |
87679-37-6 |
ACE Inhibitor |
|
Trifluridine |
70-00-8 |
Antiviral/Antineoplastic | |
Valbenazine Tosylate |
1639208-54-0 |
VMAT2 inhibitor |
|
Vecuronium Bromide |
50700-72-6 |
NMBA |
|
Voxelotor |
1446321-46-5 |
GnRH Antagonist |
Farmhispania Group offers exclusive contract development and manufacturing under strict confidentiality.
In selected products Farmhispania Group can also offer you finished dosage form through our Partner.
For further information regarding any of our products please contact our generic API BU
Product currently under patent protection could be available only for R&D purposes, if this is allowed by local laws.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e)(1).
Products covered by valid patents in any country are not offered or supplied to these countries.
However, the final responsibility lies exclusively on the buyer.
